跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELAHERE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ELAHERE
Authorized
STANDARD
ELAHERE
Abbvie Corporation
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
69e64e9395b59127
Company
Abbvie Corporation
Type
Standard
Approval Details
Approval Id
69e64e9395b59127
Drug Approval Canada Name
ELAHERE
Product Name
ELAHERE
Status
Marketed
Status Date
2026-01-09
Original Market Date
2026-01-09
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
10:00.00
Atc Original
L01FX26 MIRVETUXIMAB SORAVTANSINE
Aig Number
0167344001
Company Name
Abbvie Corporation
Company Address
8401 Trans-Canada Highway Saint-Laurent Quebec Canada H4S 1Z1
Company Detail Path
/organization/abbvie-corporation
Company Information
Pharmaceutical Company Name
Abbvie Corporation
Country Name
Canada
Province Name
Quebec
City Name
saint-laurent,quebec,country_ca
Address
8401 rte Transcanadienne
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
69e64e9395b59127
Type
Standard
Back to Health Canada Approvals